Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
批准号:
7873969
负责人:
STEPHEN HINSHAW
金额:
$33.64万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2011-06-30
关键词:
Academic achievementAgeAttentionAttention deficit hyperactivity disorderBehavior TherapyChildChildhoodClinicCommunitiesComplementConsultationsControl GroupsDSM-IVDataDecision MakingDiseaseEducational CurriculumEffectivenessEvaluationFamilyFunctional disorderFundingGoalsGrantHome environmentHyperactive behaviorImpairmentImpulsivityInterventionLanguageLifeLiteratureMeasuresMedicineMental disordersModelingModificationNeurocognitiveOutcomeParent-Child RelationsParenting behaviorParentsPharmaceutical PreparationsProtocols documentationPublishingRandomizedRandomized Clinical TrialsRandomized Controlled TrialsRecruitment ActivityRehabilitation therapyRelative (related person)ResearchSchoolsSiteSocial FunctioningStructureSymptomsTestingTrainingTreatment outcomeWorkactive methodbasebehavior changeblinddesignevidence basefollow-upimprovedinattentionintervention effectnovelpeerprogramspsychosocialpublic health relevanceskillsskills trainingsocialtau Proteinsteachertherapy developmenttreatment as usualtreatment effecttrial comparing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Attention Deficit Hyperactivity Disorder-Predominantly Inattentive Type (ADHD-I) is a highly prevalent and serious childhood psychiatric disorder [with evidence that impairment is severe and persistent]. Children with ADHD-I have a profile of attention deficits, comorbid disorders, social impairments, and neurocognitive dysfunction that differs from that associated with ADHD-Combined Type (ADHD-C). The extent of these differences precludes straightforward assumptions that treatment outcome findings for ADHD-C can be generalized to ADHD-I. Through funding from an R21 Treatment Development grant, we have developed a novel psychosocial treatment (Integrated Multi-Setting Psychosocial Treatment--IPT) for ADHD-I. IPT combines a standard behavioral treatment for ADHD (parent training) that has been adapted for ADHD-I, with child life skills training (supportive strategies drawn from rehabilitation medicine) and with teacher consultation. As part of the R21, we conducted a small-scale randomized controlled trial comparing IPT to an untreated control group and demonstrated (a) significant treatment effects on inattention, and academic and social impairment, and (b) feasibility and acceptability of the model. These positive outcomes justify the current application, which aims to provide a dual-site, randomized clinical trial of IPT. We will randomize [210] children with ADHD-I ages 7-11 (2nd-5th grades) to IPT ([N=78]), Parent-Focused Training (PFT, [N=78]), or Treatment as Usual, TAU ([N=54]). The goal of the RCT is to test whether IPT provides superior reduction of DSM-IV inattention symptoms as rated by parents and teachers (the primary endpoint), in comparison to standard community treatment, TAU; and to [PFT], which constitutes an active treatment that is effective at reducing symptoms of ADHD. We will include medicated and unmedicated children and will recruit from a broad array of clinics and schools, consistent with our goal of increasing generalizability. Secondary analyses will evaluate the effects of the intervention across multiple domains of impairment including academic and social functioning and on objective measures of attention and parenting derived from observations during standard clinic-based tasks, and on curriculum-based measures of academic achievement. We predict that ADHD-I symptoms will be significantly lower and, secondarily, that academic and social functioning will be significantly higher, in IPT relative to TAU]. We hypothesize that ADHD-I symptoms will be significantly lower and, secondarily, that academic and social functioning will be significantly higher, in the IPT group relative to [PFT]. We will also examine the durability of treatment gains at [5-7] month follow-up. We predict that ADHD-I symptoms will remain lowest and academic/social functioning will remain highest in the IPT group relative to the other groups at follow-up. PUBLIC HEALTH RELEVANCE STATEMENT Attention-deficit\Hyperactivity Disorder, Predominantly Inattentive type is a prevalent and serious childhood psychiatric disorder which severely and persistently impacts a child's functioning at school, at home, and with peers. This study aims to evaluate the effectiveness of a behavioral intervention, integrating school, home and child skills components, for improving attentional symptoms and academic and social functioning in these children.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
-
批准号:8071503
-
项目类别:
-
资助金额:$64.59万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
-
批准号:7847474
-
项目类别:
-
资助金额:$67.69万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
-
批准号:7648095
-
项目类别:
-
资助金额:$68.34万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
FOLLOW-UP OF THE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ATTENTION DEFICIT H
-
批准号:7962266
-
项目类别:
-
资助金额:$48.74万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
FOLLOW-UP OF THE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ATTENTION DEFICIT H
-
批准号:8248676
-
项目类别:
-
资助金额:$51.73万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
Integrated Multi-Setting Psychosocial Treatment for ADHD-Inattentive Type
-
批准号:8299152
-
项目类别:
-
资助金额:$63.13万
-
财政年份:2008
-
负责人:STEPHEN HINSHAW
-
依托单位:
Functional Neuroanatomical Deficits in ADHD Families
-
批准号:6623674
-
项目类别:
-
资助金额:$2.84万
-
财政年份:2002
-
负责人:STEPHEN HINSHAW
-
依托单位:
Functional Neuroanatomical Deficits in ADHD Families
-
批准号:6469438
-
项目类别:
-
资助金额:$2.96万
-
财政年份:2002
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTISITE MULTIMODAL TREATMENT STUDY OF CHILDREN WITH A
-
批准号:2730713
-
项目类别:
-
资助金额:$30.39万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD (MTA)
-
批准号:2034010
-
项目类别:
-
资助金额:$55.37万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD(MTA)
-
批准号:2034008
-
项目类别:
-
资助金额:$83.73万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD(MTA)
-
批准号:2249812
-
项目类别:
-
资助金额:$71.77万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
PHARMACOLOGIC AND PSYCHOSOCIAL INTERVENTIONS FOR ADHD
-
批准号:3553989
-
项目类别:
-
资助金额:$1.44万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
PHARMACOLOGIC AND PSYCHOSOCIAL INTERVENTIONS FOR ADHD
-
批准号:2249810
-
项目类别:
-
资助金额:$58.65万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
PHARMACOLOGIC AND PSYCHOSOCIAL INTERVENTIONS FOR ADHD
-
批准号:2249811
-
项目类别:
-
资助金额:$3.66万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD
-
批准号:6354445
-
项目类别:
-
资助金额:$1.67万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
PHARMACOLOGIC AND PSYCHOSOCIAL INTERVENTIONS FOR ADHD
-
批准号:3553990
-
项目类别:
-
资助金额:$14.17万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
PHARMACOLOGIC AND PSYCHOSOCIAL INTERVENTIONS FOR ADHD
-
批准号:2249808
-
项目类别:
-
资助金额:$13.99万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MULTIMODAL TREATMENT STUDY OF CHILDREN WITH ADHD
-
批准号:2890545
-
项目类别:
-
资助金额:$37.95万
-
财政年份:1992
-
负责人:STEPHEN HINSHAW
-
依托单位:
MEDIATORS OF COMPETENCE AND IMPAIRMENT IN ADHD GIRLS
-
批准号:2033747
-
项目类别:
-
资助金额:$35.41万
-
财政年份:1990
-
负责人:STEPHEN HINSHAW
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: